Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultrastruct Pathol ; 47(4): 304-323, 2023 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-36988127

RESUMO

This study was performed to explore in detail the toxic effects of Tributyltin Chloride (TBT) on the pituitary-testicular axis and the possible amelioration with Hesperidin. Seventy-two adult male albino rats were divided into four groups: Control group (I), TBT-treated group (II), TBT+Hesperidin group (III), and Recovery group (IV). Body and testicular weights were measured. Blood samples were taken to estimate serum levels of testosterone, FSH and LH hormones by enzyme-linked immunosorbent assay (ELISA). Malondialdehyde (MDA) level was measured in testes homogenates. Tissue samples from the pituitary glands and testes were processed for light, electron microscope examination, and immunohistochemical detection of anti-FSH, and Ki67 proteins. Results showed a statistically significant decrease in testicular weight, serum testosterone, FSH and LH levels and a significant increase in tissue MDA in the TBT group when compared to the control group. TBT treatment caused severe histopathological changes with decreased area percent of PAS-stained basophils, and anti FSH immuno-stained gonadotrophs in the pituitary gland. The testes of group II also showed marked tissue damage, cell loss with decreased epithelial height and decreased number of proliferating spermatogenic cells. Hesperidin supplementation with TBT proved significant amelioration of the previously mentioned parameters in both glands which could improve male fertility. In conclusion: The flavonoid Hesperidin has the potential to protect against the reproductive damage induced by TBT in susceptible individuals.


Assuntos
Hesperidina , Testículo , Humanos , Adulto , Masculino , Ratos , Hesperidina/farmacologia , Hesperidina/metabolismo , Hipófise/metabolismo , Testosterona , Animais
2.
Public Health Nutr ; 25(6): 1631-1638, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-34462043

RESUMO

OBJECTIVE: This study aims to investigate the association between iron body status and postpartum depression (PPD) among mothers during the postpartum period. DESIGN: This is a case-control study. SETTING: Governmental primary health care centres in the Gaza Strip, Palestine. PARTICIPANTS: This study involved 300 mothers a month after delivery, with one 150 mothers that were recruited in the cases group who were diagnosed with PPD based on Edinburgh Postnatal Depression Scale (EPDS) ≥ 10. The control group included 150 mothers did not have PPD (EPDS < 10). Body iron status is represented by the index of sTfR/log ferritin. RESULTS: Among PPD mothers, 43·3 % had low ferritin level v. 15·3 % for controls (P < 0·001) and cases v. controls difference in mean Hb level was -0·61 (95 % CI -0·86, -0·35). The results of the multiple logistic regression reported that there is a statistically significant association between PPD and the body iron status existed, as mothers who suffered from iron deficiency (ID) were three times more likely to have PPD (ORadj 3·25; P = 0·015). Furthermore, the results of the final regression model showed that the other factors that can lead to PPD are absence of psychological guidance services (ORadj 8·54; P = 0·001), suffering from undesired feeling in the last pregnancy (ORadj 1·77; P = 0·034), in addition to having one of the mental health disorders in the last pregnancy (P = 0·001). CONCLUSION: Body iron status might be a risk factor for postpartum depression and other possibilities of reverse causality may worsen the condition.


Assuntos
Depressão Pós-Parto , Deficiências de Ferro , Estudos de Casos e Controles , Depressão Pós-Parto/epidemiologia , Depressão Pós-Parto/etiologia , Feminino , Ferritinas , Humanos , Ferro , Oriente Médio/epidemiologia , Mães/psicologia , Gravidez , Escalas de Graduação Psiquiátrica , Fatores de Risco
3.
Ultrastruct Pathol ; 41(1): 36-50, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28029272

RESUMO

Hypertensive heart diseases affect millions of people worldwide. We aimed to investigate the hypertensive left ventricular histological changes and assess the effectiveness of bone marrow derived mesenchymal stem cells (MSCs) therapy in the treatment of hypertensive cardiomyopathy. Adult male albino rats were assigned into two groups: group I (control), group II (Experimental) subdivided into subgroup IIa (hypertensive) and subgroup IIb (stem cell therapy). Left ventricles (LVs) were processed for light and electron microscope. Mallory's trichrome and immunostaining for caspase-3 and desmin were carried out. Hypertension caused left ventricular histological and immunohistochemical changes that had been effectively improved by MSCs therapy.


Assuntos
Cardiomiopatias/cirurgia , Ventrículos do Coração/fisiopatologia , Hipertensão Renovascular/complicações , Hipertrofia Ventricular Esquerda/cirurgia , Transplante de Células-Tronco Mesenquimais , Função Ventricular Esquerda , Remodelação Ventricular , Animais , Cardiomiopatias/etiologia , Cardiomiopatias/patologia , Cardiomiopatias/fisiopatologia , Caspase 3/metabolismo , Células Cultivadas , Desmina/metabolismo , Modelos Animais de Doenças , Ventrículos do Coração/metabolismo , Ventrículos do Coração/ultraestrutura , Hipertensão Renovascular/fisiopatologia , Hipertrofia Ventricular Esquerda/etiologia , Hipertrofia Ventricular Esquerda/patologia , Hipertrofia Ventricular Esquerda/fisiopatologia , Imuno-Histoquímica , Masculino , Microscopia Eletrônica de Transmissão , Ratos , Regeneração , Coloração e Rotulagem/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...